NTRA Q4 2018 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q4 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$67M+24.6% YoY

Gross Profit

$24M36.1% margin

Operating Income

-$30M-44.4% margin

Net Income

-$32M-47.5% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

+2.6%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$15M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$268M

Total Liabilities

$236M

Stockholders' Equity

$32M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$67M	$54M	+24.6%
Gross Profit	$24M	$17M	+41.9%
Operating Income	-$30M	-$45M	+33.8%
Net Income	-$32M	-$46M	+30.0%

Revenue Segments

Product

$63M48%

Panorama Nipt

$36M27%

Hcs

$24M18%

Licensing And Other

$4M3%

Other Genetic Tests

$3M2%

Constellation

$1M1%

Geographic Segments

U

$60M96%

Other Geographic Areas

$2M3%

Americas Excluding Us

$843,0001%